CHEMDOODLE LICENSE OR EQUAL
ID: 75F40125Q00087Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Professional Organizations (813920)

PSC

IT AND TELECOM - DATA CENTER PRODUCTS (HARDWARE AND PERPETUAL LICENSE SOFTWARE) (7C20)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
  1. 1
    Posted Jan 10, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 10, 2025, 12:00 AM UTC
  3. 3
    Due Jan 16, 2025, 4:00 AM UTC
Description

The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking quotes for a ChemDoodle site license or an equivalent chemical drawing tool through a Total Small Business Set-Aside procurement. The software must be compatible with Windows, Mac, and Linux operating systems and include features such as interactive drawing capabilities, various export and import formats, IUPAC naming functionalities, and integration with Excel for property calculations. This procurement is crucial for providing FDA users with the necessary tools for chemical structure representation and analysis, with the contract set to span from January 21, 2025, to January 20, 2026. Interested vendors should contact Tiffany Hatcher at Tiffany.Hatcher@fda.hhs.gov or call 240-402-1492 for further details.

Point(s) of Contact
Files
Title
Posted
Jan 10, 2025, 5:04 PM UTC
The U.S. Food and Drug Administration (FDA) is soliciting quotes for the ChemDoodle Advanced Software Suite, a chemical drawing tool, through a Total Small Business Set-Aside procurement. The software is intended for all FDA users and must be compatible with Windows, Mac, and Linux operating systems, including onsite maintenance and technical support. Key features required include interactive drawing capabilities, various export and import formats, IUPAC naming functionalities, and integration with Excel for calculating properties of chemical structures. The contract, which is firm-fixed price, spans one year from January 21, 2025, to January 20, 2026, with specific deliverables and maintenance provisions outlined. The FDA emphasizes that the contractor must provide essential support and access to updates during the contract period. The document details the inspection and acceptance criteria, performance evaluation processes, and compliance with electronic invoicing through the Department of Treasury’s Invoice Processing Platform, ensuring adherence to federal regulations and efficiency in payment processing.
Lifecycle
Title
Type
Combined Synopsis/Solicitation
Similar Opportunities
Dosimeters
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking contractors to provide dosimetry services for occupational radiation monitoring, including the supply of Optically Stimulated Luminescence (OSL) and Thermoluminescent Dosimeters (TLD). The primary objective is to ensure that radiation exposure for employees across various FDA offices and laboratories remains within the limits set by the Nuclear Regulatory Commission and the Occupational Safety and Health Administration. This procurement is critical for maintaining safety standards and monitoring radiation exposure effectively, supporting a workforce of up to 2,000 employees across multiple locations. Interested vendors must submit their quotes by April 7, 2025, and can contact Elena Tatarov at elena.tatarov@fda.hhs.gov for further details regarding the solicitation number FDA-25-1285024.
Drug Utilization: Hospital Inpatient & Emergency Dept. Data (Recompete)
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a contract titled "Drug Utilization: Hospital Inpatient & Emergency Dept. Data (Recompete)." The primary objective of this procurement is to gain immediate and unlimited access to commercially available drug utilization data for both adult and pediatric populations in hospitals, which will support the FDA's regulatory activities related to drug safety and utilization assessments. This data is crucial for enhancing public health safety and informing regulatory decision-making regarding marketed drugs. Interested parties should note that the contract may cover up to $5 million over several years, with a response deadline of April 16, 2025. For further inquiries, potential offerors can contact Ryan Alexander at ryan.alexander@fda.hhs.gov.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense (DoD) is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) related to pharmaceutical agents under the Uniform Formulary (UF) for the Military Health System (MHS). This procurement aims to establish an effective pharmacy benefits program, ensuring the selection of clinically and cost-effective pharmaceutical agents as mandated by law (10 U.S.C. § 1074g). The upcoming Pharmacy and Therapeutics (P&T) Committee meeting, scheduled for May 7-8, 2025, will review newly approved drugs, with quotes due by April 17, 2025. Interested manufacturers should submit their proposals, including a signed quote and National Drug Code (NDC) price list, to the primary contact, Keith Marasigan, at keith.b.marasigan2.ctr@health.mil, or the secondary contact, Stephanie Erpelding, at stephanie.j.erpelding.civ@health.mil.
Purchase of Lab Supplies
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide various lab supplies, including cleaning and sanitation products, under solicitation number 75N98025Q00021. The procurement aims to ensure the NIH is equipped with essential supplies such as paper towels, disinfectant wipes, and hand soap, which are critical for maintaining hygiene and safety in healthcare environments. This opportunity includes a partial small business set-aside, encouraging participation from small businesses, including service-disabled veteran-owned and women-owned enterprises, with a focus on timely delivery within a 10-day timeframe. Interested vendors must submit their quotes via email by 4:30 PM Eastern Daylight Time on April 9, 2025, and can direct inquiries to Carol Hayden at haydenc@od.nih.gov.
Graph Prism Software
Buyer not available
The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole source contract for GraphPad Prism software, specifically a 125-seat license, to GraphPad Software, LLC. This software is essential for transforming raw data into professional graphical presentations, facilitating collaboration among over 100 researchers at NMRC without requiring extensive training. The contract, valued at approximately $36,250, will cover a one-year period and includes vendor technical support and software updates. Interested parties can reach out to Shamai Carter at shamai.m.carter.civ@health.mil or Deborah Sharpe at deborah.m.sharpe2.civ@health.mil for further information.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
Food and Drug Administration (FDA) Regulatory Compliance Training
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking proposals for FDA Regulatory Compliance Training aimed at enhancing the competency of personnel involved in FDA-regulated research activities. The training will cover essential areas such as Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and Quality Systems Regulations (QSR), ensuring compliance with federal and Department of Defense regulations. This initiative is critical for the U.S. Army Medical Research and Development Command (USAMRDC) as it supports the development of FDA-approved pharmaceuticals and devices for military personnel. Interested contractors should contact Matthew Gembe at matthew.w.gembe.civ@health.mil or 301-619-1350 for further details, with proposals due in alignment with the specified timelines in the solicitation documents.
Dimethyl Fumarate DR Presolicitation
Buyer not available
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
CORHQ-25-Q-0134 S-AutoDesk AEC License
Buyer not available
The Federal Deposit Insurance Corporation (FDIC) is soliciting quotes for the procurement of AutoDesk AEC licenses under solicitation number CORHQ-25-Q-0134. This opportunity involves providing subscription maintenance services for AutoDesk software, which is critical for managing architectural projects and documentation related to the FDIC's physical locations. The contract is aimed at ensuring long-term support and maintenance of software essential for the FDIC's operational needs, with the service period running from July 28, 2025, to July 27, 2026. Interested vendors must submit their quotes by 1:00 PM EST on May 8, 2025, and direct any inquiries to Ellisha Smith at ellismith@FDIC.gov or by phone at 571-212-4449.
Liquids Analytics Platform
Buyer not available
The Federal Energy Regulatory Commission (FERC) is seeking proposals for the acquisition of the Law IQ Liquids Analytics Platform, which includes a base contract and four optional years. This platform is essential for enhancing the efficiency of oil program research by providing comprehensive access to pipeline tariff data, thereby facilitating the analysis of tariff and rate trends critical to the Commission's mission. The platform will significantly streamline the research process, particularly for mergers and acquisitions, by converting complex tariff PDF submissions into an easily searchable database. Interested vendors must submit their quotes via email to Trey Hair by April 8, 2025, at 12:00 PM Eastern Time, with all inquiries directed to him by April 7, 2025. The procurement emphasizes quality control, requiring all software to be free of malicious code, and includes provisions for up to five user licenses and an optional newsletter.